Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
1.0 |
High Similarity |
NPD6797 |
Phase 2 |
0.9938 |
High Similarity |
NPD7251 |
Discontinued |
0.9755 |
High Similarity |
NPD7808 |
Phase 3 |
0.9691 |
High Similarity |
NPD7472 |
Approved |
0.963 |
High Similarity |
NPD7054 |
Approved |
0.9451 |
High Similarity |
NPD7074 |
Phase 3 |
0.9398 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9273 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.9207 |
High Similarity |
NPD6166 |
Phase 2 |
0.9207 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9207 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9096 |
High Similarity |
NPD3818 |
Discontinued |
0.9074 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8834 |
High Similarity |
NPD3817 |
Phase 2 |
0.8827 |
High Similarity |
NPD1934 |
Approved |
0.8773 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8688 |
High Similarity |
NPD1512 |
Approved |
0.8667 |
High Similarity |
NPD3882 |
Suspended |
0.8659 |
High Similarity |
NPD2801 |
Approved |
0.8605 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD1511 |
Approved |
0.8503 |
High Similarity |
NPD7075 |
Discontinued |
0.8476 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8443 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8383 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8373 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8343 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8293 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8282 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8221 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8171 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8132 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8114 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8092 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.8081 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8075 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8035 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8025 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8024 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7953 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7944 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7944 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7929 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.791 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7901 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7895 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7895 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7882 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7865 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7844 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7841 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7833 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7784 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7753 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7751 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7737 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7727 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7714 |
Intermediate Similarity |
NPD919 |
Approved |
0.7708 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7702 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7702 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7665 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7663 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7634 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7627 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7617 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7617 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7617 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7614 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7605 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD1240 |
Approved |
0.759 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7551 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7542 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7541 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7529 |
Intermediate Similarity |
NPD37 |
Approved |
0.75 |
Intermediate Similarity |
NPD3750 |
Approved |
0.75 |
Intermediate Similarity |
NPD4966 |
Approved |
0.75 |
Intermediate Similarity |
NPD4965 |
Approved |
0.75 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7487 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD943 |
Approved |
0.7475 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7475 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7474 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7474 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7471 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7448 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7439 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7437 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7437 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7401 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7398 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7398 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7396 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD3749 |
Approved |
0.735 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7305 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7249 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7249 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7225 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7225 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7225 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7213 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD3748 |
Approved |
0.72 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.715 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD920 |
Approved |
0.7135 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7129 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7115 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7112 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7085 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7069 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7062 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7062 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7039 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD1243 |
Approved |
0.703 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7029 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7011 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7005 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD6651 |
Approved |
0.697 |
Remote Similarity |
NPD9494 |
Approved |
0.6951 |
Remote Similarity |
NPD1203 |
Approved |
0.6946 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6933 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6931 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6919 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6919 |
Remote Similarity |
NPD2344 |
Approved |
0.6914 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6897 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6872 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6868 |
Remote Similarity |
NPD5353 |
Approved |
0.6864 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6862 |
Remote Similarity |
NPD2163 |
Approved |
0.6845 |
Remote Similarity |
NPD3268 |
Approved |
0.6845 |
Remote Similarity |
NPD2403 |
Approved |
0.6836 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6828 |
Remote Similarity |
NPD5711 |
Approved |
0.6828 |
Remote Similarity |
NPD5710 |
Approved |
0.6827 |
Remote Similarity |
NPD7930 |
Approved |
0.681 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.681 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6805 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6802
|
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |